IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.440
+0.040 (2.86%)
At close: Apr 2, 2026, 4:00 PM EDT
1.530
+0.090 (6.25%)
After-hours: Apr 2, 2026, 7:43 PM EDT
IN8bio Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IN8bio stock has a target of 6.00, which predicts a 316.67% increase from the current stock price of 1.44.
Price Target: $6.00 (+316.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for IN8bio is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +316.67% | Mar 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $240 → $180 | Strong Buy | Maintains | $240 → $180 | +12,400.00% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +16,566.67% | Feb 12, 2025 |
| Jones Trading | Jones Trading | Hold → Strong Buy Upgrades $36 | Hold → Strong Buy | Upgrades | $36 | +2,400.00% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $240 | Strong Buy | Reiterates | $240 | +16,566.67% | Nov 26, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
846.35K
EPS This Year
-1.75
from -4.44
EPS Next Year
-1.98
from -1.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | 3.5M | |||
| Avg | n/a | 846,345 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.91 | -0.46 | |||
| Avg | -1.75 | -1.98 | |||
| Low | -2.85 | -3.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.